Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Afsaneh H

Hematology Oncology, Lorestan University of Medical Science, Khoramabad, Iran

Biography

Afsaneh H is affilated to "Hematology Oncology, Lorestan University of Medical Science, Khoramabad, Iran". His main research article is processed as Ependymoma as a Secondary Malignancy after Treatment of Non- Hodgkin Lymphoma.
Publications

Ependymoma as a Secondary Malignancy after Treatment of Non- Hodgkin Lymphoma

Therapeutic advances in the treatment of paediatric neoplasms have improved the prognosis but have also increased the risk of developing rare second malignant neoplasms (SMNs) in late period after chemotherapy or radiation course. We are going to report a patient therapy-related solid tumors (brain ependymoma after non Hodgkin lymphoma) short... Read More»

Mehran K, Zareifar S, Mandana T, Babak A, Afsaneh H, Karmella K and Maral M

Case Report: OMICS J Radiol 2017, 6: 247

DOI: 10.4172/2167-7964.1000247

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top